1150
FEXUPRAZAN, A NOVEL POTASSIUM-COMPETITIVE ACID BLOCKER VS. ESOMEPRAZOLE IN INDIAN PATIENTS WITH EROSIVE ESOPHAGITIS: A PHASE 3, MULTICENTRE, RANDOMIZED, ACTIVE-CONTROLLED STUDY
Date
May 6, 2025
Explore related products in the following collection:
